Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
The Healthcare M&A Wave
Disc Medicine: The CRL Has Created A Cleaner Bull Case
Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More
LH vs. CRL: Which Stock Is the Better Value Option?
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Charles River Associates (CRA) to Present at the Sidoti Small-Cap Virtual Conference
Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Charles River Laboratories to Present at William Blair and Jefferies Conferences
Here Are Friday’s Top Wall Street Analyst Research Calls: Best Buy, Cogent Communications, Dell Technologies, EPAM Systems, Federal Realty, Gap, Snowflake, Viper Energy, and More
Charles River Laboratories International Inc (CRL) Shares Surge 5.0% -- What GF Score of 72 Tells Investors
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Charles River Laboratories International Inc (CRL) Stock Down 5.2% -- Now Undervalued? GF Score: 79/100
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
Charles River Laboratories International Q1 Earnings Call Highlights
LH vs. CRL: Which Stock Is the Better Value Option?
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript
Charles River Q1 Review: Near-Term Stability But Long-Term Risks (Downgrade)
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics
Charles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue Estimates
Charles River Associates (CRA) Reports Financial Results for the First Quarter of 2026
Charles River Associates (CRA) Declares Quarterly Cash Dividend of $0.57 Per Common Share
Charles River beats quarterly estimates on steady demand for drug development services
Charles River Laboratories Announces First-Quarter 2026 Results
Charles River (CRL) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities
Here's Why Charles River Laboratories (CRL) is a Strong Value Stock
Charles River Associates (CRA) to Host First-Quarter Fiscal 2026 Financial Results Conference Call on May 7
Charles River Highlights Effectiveness of VCGs in Toxicology
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Massachusetts Financial Services Co. MA Takes Position in Charles River Laboratories International, Inc. $CRL
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of “Moderate Buy” from Brokerages
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL
Contravisory Investment Management Inc. Takes $1.22 Million Position in Charles River Laboratories International, Inc. $CRL
Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report?
Algert Global LLC Buys 39,586 Shares of Charles River Laboratories International, Inc. $CRL
Charles River Laboratories International, Inc. (CRL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Cresset Asset Management LLC Has $1.36 Million Stock Position in Charles River Laboratories International, Inc. $CRL
Charles River Laboratories International, Inc. (CRL) Presents at TD Cowen 46th Annual Health Care Conference Transcript